ILK and chronic kidney disease: Therefore, to further study whether ILK played a role in the vascular alterations observed in the in vivo CKD model and to identify the cell type responsible for them, we decided to perform in vitro experiments exposing vascular smooth muscle cells, the predominant cell type in the vascular wall, to the uremic toxins pCS and IS.